Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Boddu PC"'
Autor:
Zeidan, AM, Boddu, PC, Patnaik, MM, Bewersdorf, JP, Stahl, M, Rampal, RK, Shallis, RM, Steensma, DP, Savona, MR, Sekeres, MA, Roboz, GJ, DeAngelo, DJ, Schuh, AC, Padron, E, Zeidner, JF, Walter, RB, Onida, F, Fathi, AT, DeZern, A, Hobbs, G, Stein, EM, Vyas, P, Wei, AH, Bowen, DT, Montesinos, P, Griffiths, EA, Verma, AK, Keyzner, A, Bar-Natan, M, Navada, SC, Kremyanskaya, M, Goldberg, AD, Al-Kali, A, Heaney, ML, Nazha, A, Salman, H, Luger, S, Pratz, KW, Konig, H, Komrokji, R, Deininger, M, Cirici, BX, Bhatt, VR, Silverman, LR, Erba, HP, Fenaux, P, Platzbecker, U, Santini, V, Wang, ES, Tallman, MS, Stone, RM, Mascarenhas, J
Publikováno v:
LANCET HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::aad6dbb5caa5579516dbfbb5aa2dcba5
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12638
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12638
Autor:
Boddu PC; Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, 300 George Street, Suite 786, New Haven, CT 06511, USA., Gupta AK; Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, 300 George Street, Suite 786, New Haven, CT 06511, USA., Roy R; Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, 300 George Street, Suite 786, New Haven, CT 06511, USA., De La Peña Avalos B; Department of Biochemistry and Structural Biology, University of Texas Health Science Center (UTHSC) at San Antonio, San Antonio, TX, USA., Olazabal-Herrero A; Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, 300 George Street, Suite 786, New Haven, CT 06511, USA., Neuenkirchen N; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA; Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA., Zimmer JT; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA., Chandhok NS; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., King D; Section of Hematology and Medical Oncology, Department of Internal Medicine and Rogel Cancer Center, University of Michigan Health, Ann Arbor, MI, USA., Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Lin H; Department of Cell Biology, Yale University School of Medicine, New Haven, CT, USA; Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA., Simon MD; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA., Dray E; Department of Biochemistry and Structural Biology, University of Texas Health Science Center (UTHSC) at San Antonio, San Antonio, TX, USA., Kupfer GM; Department of Oncology and Pediatrics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Verma A; Division of Hemato-Oncology, Department of Medicine and Department of Developmental and Molecular Biology, Albert Einstein-Montefiore Cancer Center, New York, USA., Neugebauer KM; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA; Yale Center for RNA Science and Medicine, Yale University, New Haven, CT, USA., Pillai MM; Section of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, 300 George Street, Suite 786, New Haven, CT 06511, USA; Yale Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA; Yale Center for RNA Science and Medicine, Yale University, New Haven, CT, USA; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. Electronic address: manoj.pillai@yale.edu.
Publikováno v:
Molecular cell [Mol Cell] 2024 Apr 18; Vol. 84 (8), pp. 1475-1495.e18. Date of Electronic Publication: 2024 Mar 22.
Autor:
Boddu PC, Gupta A, Roy R, De La Pena Avalos B, Herrero AO, Neuenkirchen N, Zimmer J, Chandhok N, King D, Nannya Y, Ogawa S, Lin H, Simon M, Dray E, Kupfer G, Verma AK, Neugebauer KM, Pillai MM
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 26. Date of Electronic Publication: 2023 Feb 26.
Autor:
Boddu PC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi-Kashani F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ayres M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chen Y; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gandhi V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2023 Feb 15; Vol. 129 (4), pp. 580-589. Date of Electronic Publication: 2022 Nov 29.
Autor:
Boddu PC; Section of Hematology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA., Gupta AK; Section of Hematology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA., Kim JS; Department of Oncology, Molecular Biology and Genetics, Lombardi Cancer Center, Georgetown University, Washington, DC, USA., Neugebauer KM; Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT, USA., Waldman T; Department of Oncology, Molecular Biology and Genetics, Lombardi Cancer Center, Georgetown University, Washington, DC, USA., Pillai MM; Section of Hematology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA. manoj.pillai@yale.edu.; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. manoj.pillai@yale.edu.
Publikováno v:
Communications biology [Commun Biol] 2021 Oct 13; Vol. 4 (1), pp. 1184. Date of Electronic Publication: 2021 Oct 13.
Autor:
Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA., Shallis RM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA., Boddu PC; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA., Wood B; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA., Radich J; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA; Yale Stem Cell Center and Yale RNA Center, Yale University School of Medicine, New Haven, CT, USA., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Comprehensive Cancer Center, New Haven, CT, USA; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.
Publikováno v:
Blood reviews [Blood Rev] 2020 Sep; Vol. 43, pp. 100650. Date of Electronic Publication: 2019 Dec 20.
Autor:
Zeidan AM; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu., Boddu PC; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Patnaik MM; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Bewersdorf JP; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Stahl M; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rampal RK; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shallis R; Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA., Steensma DP; Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA., Savona MR; Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Sekeres MA; Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Roboz GJ; Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA., DeAngelo DJ; Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA., Schuh AC; Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada., Padron E; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Zeidner JF; Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC, USA., Walter RB; Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Onida F; Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Fathi A; Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA., DeZern A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA., Hobbs G; Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA., Stein EM; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vyas P; MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford, UK., Wei AH; Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia., Bowen DT; Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK., Montesinos P; Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain., Griffiths EA; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Verma AK; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA., Keyzner A; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bar-Natan M; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Navada SC; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kremyanskaya M; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Goldberg AD; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Al-Kali A; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Heaney ML; Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY, USA., Nazha A; Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA., Salman H; Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY, USA., Luger S; Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA., Pratz KW; Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA., Konig H; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN, USA., Komrokji R; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Deininger M; Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA., Cirici BX; Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain., Bhatt VR; Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA., Silverman LR; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Erba HP; Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC, USA., Fenaux P; Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris, France., Platzbecker U; Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig, Germany., Santini V; Department of Medicine, University of Florence Medical School, Florence, Italy., Wang ES; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Tallman MS; Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stone RM; Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA., Mascarenhas J; Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2020 Aug; Vol. 7 (8), pp. e601-e612. Date of Electronic Publication: 2020 Jun 18.
Autor:
Galloway-Peña JR; Department of Genomic Medicine, Houston, Texas, USA.; Department of Infectious Disease, Infection Control, and Employee Health, Houston, Texas, USA., Shi Y; Department of Biostatistics, Houston, Texas, USA., Peterson CB; Department of Biostatistics, Houston, Texas, USA., Sahasrabhojane P; Department of Infectious Disease, Infection Control, and Employee Health, Houston, Texas, USA., Gopalakrishnan V; Department of Surgical Oncology, Houston, Texas, USA., Brumlow CE; Department of Infectious Disease, Infection Control, and Employee Health, Houston, Texas, USA., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Alfayez M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Boddu PC; Department of Hematology-Oncology, Yale University School of Medicine, New Haven, Connecticut, USA., Khan MAW; Department of Surgical Oncology, Houston, Texas, USA., Wargo JA; Department of Genomic Medicine, Houston, Texas, USA.; Department of Surgical Oncology, Houston, Texas, USA., Do KA; Department of Biostatistics, Houston, Texas, USA., Jenq RR; Department of Genomic Medicine, Houston, Texas, USA.; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kontoyiannis DP; Department of Infectious Disease, Infection Control, and Employee Health, Houston, Texas, USA., Shelburne SA; Department of Genomic Medicine, Houston, Texas, USA.; Department of Infectious Disease, Infection Control, and Employee Health, Houston, Texas, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Jun 24; Vol. 71 (1), pp. 63-71.
Autor:
Shallis RM; Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, USA., Boddu PC; Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, USA., Bewersdorf JP; Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, USA., Zeidan AM; Section of Hematology, Department of Medicine, Yale University School of Medicine, New Haven, USA; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, USA. Electronic address: amer.zeidan@yale.edu.
Publikováno v:
Blood reviews [Blood Rev] 2020 Mar; Vol. 40, pp. 100639. Date of Electronic Publication: 2019 Nov 08.
Autor:
Shallis RM; Division of Hematology, Department of Medicine, Yale University School of Medicine , New Haven , CT , USA., Bewersdorf JP; Division of Hematology, Department of Medicine, Yale University School of Medicine , New Haven , CT , USA., Boddu PC; Division of Hematology, Department of Medicine, Yale University School of Medicine , New Haven , CT , USA., Zeidan AM; Division of Hematology, Department of Medicine, Yale University School of Medicine , New Haven , CT , USA.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University , New Haven , CT , USA.
Publikováno v:
Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2019 Aug; Vol. 19 (8), pp. 717-729. Date of Electronic Publication: 2019 Aug 17.